CY1121075T1 - METHODS FOR THE PRODUCTION OF BUNYA VIRUS REPLIC PARTICLES - Google Patents

METHODS FOR THE PRODUCTION OF BUNYA VIRUS REPLIC PARTICLES

Info

Publication number
CY1121075T1
CY1121075T1 CY181100763T CY181100763T CY1121075T1 CY 1121075 T1 CY1121075 T1 CY 1121075T1 CY 181100763 T CY181100763 T CY 181100763T CY 181100763 T CY181100763 T CY 181100763T CY 1121075 T1 CY1121075 T1 CY 1121075T1
Authority
CY
Cyprus
Prior art keywords
particles
methods
replic
production
bunyavirus
Prior art date
Application number
CY181100763T
Other languages
Greek (el)
Inventor
Jeroen Alexander Kortekaas
Robertus Jacobus Maria Moormann
Original Assignee
Stichting Wageningen Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP11760878.6A external-priority patent/EP2618839B1/en
Application filed by Stichting Wageningen Res filed Critical Stichting Wageningen Res
Publication of CY1121075T1 publication Critical patent/CY1121075T1/en

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Η εφεύρεση αναφέρεται σε μεθόδους παραγωγής μολυσματικών σωματιδίων ρεπλικονίων bunyavirus. Αυτά τα σωματίδια ρεπλικονίων bunyavirus είναι ασφαλή και μπορούν να χρησιμοποιηθούν εκτός εγκαταστάσεων περιορισμού βιοασφάλειας. Η εφεύρεση αναφέρεται περαιτέρω σε σωματίδια ρεπλικονίων ανασυνδυασμένου bunyavirus και σε χρήσεις αυτών των σωματιδίων ρεπλικονίων ανασυνδυασμένου bunyavirus.The invention relates to methods of producing infectious bunyavirus replicate particles. These bunyavirus replicate particles are safe and can be used outside of biosecurity containment facilities. The invention further relates to recombinant bunyavirus replicate particles and to uses of these recombinant bunyavirus replicate particles.

CY181100763T 2010-09-20 2018-07-20 METHODS FOR THE PRODUCTION OF BUNYA VIRUS REPLIC PARTICLES CY1121075T1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP10177709 2010-09-20
US201161468597P 2011-03-29 2011-03-29
EP11760878.6A EP2618839B1 (en) 2010-09-20 2011-09-20 Methods to produce bunyavirus replicon particles
PCT/NL2011/050631 WO2012039607A1 (en) 2010-09-20 2011-09-20 Methods to produce bunyavirus replicon particles

Publications (1)

Publication Number Publication Date
CY1121075T1 true CY1121075T1 (en) 2019-12-11

Family

ID=66685320

Family Applications (1)

Application Number Title Priority Date Filing Date
CY181100763T CY1121075T1 (en) 2010-09-20 2018-07-20 METHODS FOR THE PRODUCTION OF BUNYA VIRUS REPLIC PARTICLES

Country Status (4)

Country Link
CY (1) CY1121075T1 (en)
PT (1) PT2618839T (en)
TR (1) TR201810380T4 (en)
ZA (1) ZA201301840B (en)

Also Published As

Publication number Publication date
TR201810380T4 (en) 2018-09-21
ZA201301840B (en) 2018-12-19
PT2618839T (en) 2018-07-26

Similar Documents

Publication Publication Date Title
CY1123339T1 (en) TRI-COMPARTMENT ARENAS AS VACCINE CARRIERS
CY1123958T1 (en) METHOD OF PREPARATION OF CARBAMOYLPYRIDONE DERIVATIVES AND INTERMEDIATES
CY1121159T1 (en) NON-INTEGRATED LINTER BODIES
HK1245838A1 (en) Compositions of and methods for in vitro viral genome engineering
PH12017550022A1 (en) Phosphoramidates for the treatment of hepatitis b virus
HK1220935A1 (en) Method and pharmaceutical compositions for the treatment of hepatitis b virus infection
DK3400293T3 (en) Modified oncolytic virus
HK1223094A1 (en) Azepane derivatives and methods of treating hepatitis b infections
AR091538A1 (en) PURIFICATION OF VIRUS TYPE PARTICLES
HK1203944A1 (en) 4-methyl-dihydropyrimidines for the treatment and prophylaxis of hepatitis b virus infection 4--
DK2903967T6 (en) ACYLAMINOPYRIMIDINE DERIVATIVES FOR THE TREATMENT OF VIRUS INFECTIONS AND OTHER DISEASES
DK3198009T3 (en) ONCOLYTIC TUMOR VIRUSES AND METHODS OF USE
DK3458594T3 (en) VSV / NDV hybrid viruses for oncolytic therapy of cancer
EP3010512A4 (en) Cyclic phosphonate substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
DK3508209T3 (en) COMPOSITIONS WITH AN ANIMATED NEWCASTLE DISEASE VIRUS AND METHODS OF USE FOR THE TREATMENT OF NEOPLASI
HK1219500A1 (en) Genetically stable oncolytic rna virus, method of manufacturing and use thereof rna
PL2658570T3 (en) Bovine viral diarrhea virus type 1b vaccine compositions and methods
FI20145081A (en) Electronic particle charging system and gas filtration method
DK2931265T6 (en) Modified AXL peptides and their use for inhibition of AXL signaling in an antimetastatic therapy
EP3013960A4 (en) Modified matrix proteins of vesicular stomatitis virus
CY1120606T1 (en) BUNYAS WITH PRODUCTORS OF FRAGINED PROTEIN GENES AND METHODS OF CREATING THESE VIRUSES
FI20125932A (en) Method for the manufacture of LED lighting devices and LED lighting devices
EP2600893A4 (en) Inactivated varicella zoster virus vaccines, methods of production, and uses thereof
BR112015017420A2 (en) influenza virus recombination
CY1121075T1 (en) METHODS FOR THE PRODUCTION OF BUNYA VIRUS REPLIC PARTICLES